PL3497104T3 - Postacie w stanie stałym soli ditosylanowej lumateperonu - Google Patents
Postacie w stanie stałym soli ditosylanowej lumateperonuInfo
- Publication number
- PL3497104T3 PL3497104T3 PL17754571T PL17754571T PL3497104T3 PL 3497104 T3 PL3497104 T3 PL 3497104T3 PL 17754571 T PL17754571 T PL 17754571T PL 17754571 T PL17754571 T PL 17754571T PL 3497104 T3 PL3497104 T3 PL 3497104T3
- Authority
- PL
- Poland
- Prior art keywords
- lumateperone
- solid state
- state forms
- ditosylate salt
- ditosylate
- Prior art date
Links
- HOIIHACBCFLJET-SFTDATJTSA-N 4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h-pyrido-[3',4':4,5]-pyrrolo[1,2,3-de]quinoxalin-8-(7h)-yl)-1-(4-fluorophenyl)-1-butanone Chemical compound C([C@@H]1N2CCN(C=3C=CC=C(C2=3)[C@@H]1C1)C)CN1CCCC(=O)C1=CC=C(F)C=C1 HOIIHACBCFLJET-SFTDATJTSA-N 0.000 title 1
- 229950003467 lumateperone Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 239000007787 solid Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/16—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/01—Sulfonic acids
- C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C309/29—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings
- C07C309/30—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of non-condensed six-membered aromatic rings of six-membered aromatic rings substituted by alkyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662372553P | 2016-08-09 | 2016-08-09 | |
| US201662382479P | 2016-09-01 | 2016-09-01 | |
| US201662382977P | 2016-09-02 | 2016-09-02 | |
| US201662400358P | 2016-09-27 | 2016-09-27 | |
| US201762486554P | 2017-04-18 | 2017-04-18 | |
| PCT/US2017/045877 WO2018031535A1 (en) | 2016-08-09 | 2017-08-08 | Solid state forms of lumateperone ditosylate salt |
| EP17754571.2A EP3497104B1 (en) | 2016-08-09 | 2017-08-08 | Solid state forms of lumateperone ditosylate salt |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3497104T3 true PL3497104T3 (pl) | 2022-02-21 |
Family
ID=59656224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17754571T PL3497104T3 (pl) | 2016-08-09 | 2017-08-08 | Postacie w stanie stałym soli ditosylanowej lumateperonu |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US11332469B2 (pl) |
| EP (2) | EP3497104B1 (pl) |
| ES (1) | ES2901375T3 (pl) |
| HR (1) | HRP20211666T1 (pl) |
| HU (1) | HUE057055T2 (pl) |
| IL (1) | IL264521A (pl) |
| PL (1) | PL3497104T3 (pl) |
| SI (1) | SI3497104T1 (pl) |
| WO (1) | WO2018031535A1 (pl) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20140146192A (ko) | 2012-04-14 | 2014-12-24 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 유기 화합물 |
| PL3497104T3 (pl) * | 2016-08-09 | 2022-02-21 | Teva Pharmaceuticals International Gmbh | Postacie w stanie stałym soli ditosylanowej lumateperonu |
| EP3525763B1 (en) | 2016-10-12 | 2025-03-05 | Intra-Cellular Therapies, Inc. | Amorphous solid dispersions |
| RU2767410C2 (ru) | 2017-03-24 | 2022-03-17 | Интра-Селлулар Терапиз, Инк. | Новые композиции и способы |
| EP3609501A4 (en) | 2017-04-10 | 2020-08-19 | Dr. Reddy's Laboratories Limited | AMORPHIC FORM AND SOLID DISPERSIONS OF LUMATEPERONE P-TOSYLATE |
| EP3658144B1 (en) | 2017-07-26 | 2022-01-26 | Intra-Cellular Therapies, Inc. | Pyridopyrroloquinoxaline compounds, their compositions and uses in therapy |
| US11440911B2 (en) | 2017-09-26 | 2022-09-13 | Intra-Cellular Therapies, Inc. | Salts and crystals |
| EP3717484A4 (en) | 2017-11-27 | 2021-08-04 | Egis Gyógyszergyár Zrt. | PROCESS FOR THE PRODUCTION OF LUMATEPERON AND ITS SALT |
| WO2019178484A1 (en) * | 2018-03-16 | 2019-09-19 | Intra-Cellular Therapies, Inc. | Novel methods |
| AU2019280850C1 (en) * | 2018-06-06 | 2025-02-13 | Intra-Cellular Therapies, Inc. | Novel salts and crystals |
| EP3801527B1 (en) | 2018-06-08 | 2025-02-19 | Intra-Cellular Therapies, Inc. | Fused gamma-carbolines for acute treatment of anxiety or depression |
| CA3240552A1 (en) * | 2018-06-11 | 2019-12-19 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| US12144808B2 (en) | 2018-08-29 | 2024-11-19 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| BR112021003655A2 (pt) * | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
| WO2020047408A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| EP3887374A2 (en) | 2018-11-27 | 2021-10-06 | Teva Pharmaceuticals International GmbH | Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof |
| CN113473988A (zh) * | 2018-12-14 | 2021-10-01 | 细胞内治疗公司 | 无定形固体分散体 |
| WO2020131899A1 (en) | 2018-12-17 | 2020-06-25 | Intra-Cellular Therapies, Inc. | Organic compound |
| JP7649743B2 (ja) | 2018-12-21 | 2025-03-21 | イントラ－セルラー・セラピーズ・インコーポレイテッド | 有機化合物 |
| WO2021007245A1 (en) | 2019-07-07 | 2021-01-14 | Intra-Cellular Therapies, Inc. | Novel methods |
| US12478623B2 (en) | 2019-09-25 | 2025-11-25 | Intra-Cellular Therapies, Inc. | Methods of treating central nervous system disorders comprising administering lumateperone and a nitric oxide donor |
| EP4072554A4 (en) | 2019-12-11 | 2023-12-20 | Intra-Cellular Therapies, Inc. | ORGANIC CONNECTION |
| WO2022195500A1 (en) * | 2021-03-16 | 2022-09-22 | Ami Organics Ltd. | A process for the preparation of lumateperone tosylate intermediate |
| US12414948B2 (en) | 2022-05-18 | 2025-09-16 | Intra-Cellular Therapies, Inc. | Methods |
| KR20250043448A (ko) * | 2022-07-30 | 2025-03-28 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 신규 염 및 결정 |
| US20250352469A1 (en) | 2024-05-16 | 2025-11-20 | Intra-Cellular Therapies, Inc. | Novel compositions, devices, and methods |
| CN118566395B (zh) * | 2024-08-02 | 2024-10-25 | 则正(济南)生物科技有限公司 | 测定甲苯磺酸卢美哌隆口崩片中杂质含量的方法、应用和系统 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102107954B1 (ko) | 2007-03-12 | 2020-05-07 | 인트라-셀룰라 써래피스, 인코퍼레이티드. | 치환된 헤테로환 융합 감마-카르볼린 합성 |
| AU2009223701B2 (en) | 2008-03-12 | 2015-04-16 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines solid |
| WO2012071425A1 (en) | 2010-11-22 | 2012-05-31 | Teva Pharmaceutical Industries Ltd. | Solid state forms of sorafenib besylate, and processes for preparations thereof |
| EP3436455A4 (en) | 2016-03-28 | 2019-09-04 | Intra-Cellular Therapies, Inc. | NOVEL SALTS AND CRYSTALS |
| US11014925B2 (en) | 2016-03-28 | 2021-05-25 | Intra-Cellular Therapies, Inc. | Co-crystals of 1-(4-fluoro-phenyl)-4-((6bR,1OaS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H- pyrido[3′,4′:4,51_pyrrolo [1,2,3-delqcuinoxalin-8-yl)-butan-1-one with nicotinamide or isonicotinamide |
| PL3497104T3 (pl) * | 2016-08-09 | 2022-02-21 | Teva Pharmaceuticals International Gmbh | Postacie w stanie stałym soli ditosylanowej lumateperonu |
| RU2767410C2 (ru) | 2017-03-24 | 2022-03-17 | Интра-Селлулар Терапиз, Инк. | Новые композиции и способы |
| EP3717484A4 (en) | 2017-11-27 | 2021-08-04 | Egis Gyógyszergyár Zrt. | PROCESS FOR THE PRODUCTION OF LUMATEPERON AND ITS SALT |
| AU2019280850C1 (en) | 2018-06-06 | 2025-02-13 | Intra-Cellular Therapies, Inc. | Novel salts and crystals |
| CA3240552A1 (en) | 2018-06-11 | 2019-12-19 | Intra-Cellular Therapies, Inc. | Substituted heterocycle fused gamma-carbolines synthesis |
| US12144808B2 (en) | 2018-08-29 | 2024-11-19 | Intra-Cellular Therapies, Inc. | Compositions and methods |
| WO2020047408A1 (en) | 2018-08-31 | 2020-03-05 | Intra-Cellular Therapies, Inc. | Novel methods |
| BR112021003655A2 (pt) | 2018-08-31 | 2021-05-18 | Intra-Cellular Therapies, Inc. | métodos novos |
| EP3887374A2 (en) | 2018-11-27 | 2021-10-06 | Teva Pharmaceuticals International GmbH | Solid state forms of lumateperone salts and processes for preparation of lumateperone and salts thereof |
-
2017
- 2017-08-08 PL PL17754571T patent/PL3497104T3/pl unknown
- 2017-08-08 US US16/323,939 patent/US11332469B2/en active Active
- 2017-08-08 EP EP17754571.2A patent/EP3497104B1/en active Active
- 2017-08-08 SI SI201730962T patent/SI3497104T1/sl unknown
- 2017-08-08 HU HUE17754571A patent/HUE057055T2/hu unknown
- 2017-08-08 HR HRP20211666TT patent/HRP20211666T1/hr unknown
- 2017-08-08 WO PCT/US2017/045877 patent/WO2018031535A1/en not_active Ceased
- 2017-08-08 ES ES17754571T patent/ES2901375T3/es active Active
- 2017-08-08 EP EP21200789.2A patent/EP4001281A1/en active Pending
-
2019
- 2019-01-29 IL IL264521A patent/IL264521A/en unknown
-
2022
- 2022-01-07 US US17/570,502 patent/US11760757B2/en active Active
-
2023
- 2023-08-14 US US18/233,390 patent/US20230382914A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP3497104B1 (en) | 2021-10-06 |
| IL264521A (en) | 2019-05-30 |
| US20230382914A1 (en) | 2023-11-30 |
| US20190211015A1 (en) | 2019-07-11 |
| US11332469B2 (en) | 2022-05-17 |
| EP3497104A1 (en) | 2019-06-19 |
| ES2901375T3 (es) | 2022-03-22 |
| EP4001281A1 (en) | 2022-05-25 |
| US20220127268A1 (en) | 2022-04-28 |
| HUE057055T2 (hu) | 2022-04-28 |
| WO2018031535A1 (en) | 2018-02-15 |
| SI3497104T1 (sl) | 2021-12-31 |
| HRP20211666T1 (hr) | 2022-02-18 |
| US11760757B2 (en) | 2023-09-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL264521A (en) | Solid forms of lometaferon ditosylate | |
| IL257026A (en) | Solid state forms of eluxadoline | |
| SG11201706729SA (en) | Derivatives of sobetirome | |
| PT3466934T (pt) | Compostos de sulfonamida ou seus sais como inibidores da ribonucleótido-redutase para o tratamento de cancro | |
| SMT202100551T1 (it) | Derivati di sobetirome | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| SI3154526T1 (sl) | Trdne oblike sofosbuvira | |
| IL265628A (en) | Solid state forms of valbenazine | |
| IL274627A (en) | Solid forms of valbenazine | |
| IL263853A (en) | Solid state forms of palbociclib dimesylate | |
| IL246979A0 (en) | Crystalline forms of sofosbuvir | |
| ZA201706282B (en) | Solid forms of menaquinols | |
| PL3430004T3 (pl) | Postaci soli nilotynibu w stanie stałym | |
| GB201701939D0 (en) | Salt | |
| IL263673A (en) | Solid state forms of spiro-oxindole compounds | |
| ZA201803035B (en) | Biomarker of polycystic kidney disease and uses thereof | |
| IL272670A (en) | Preparation of micro-electrodes | |
| IL246569A0 (en) | Solid forms of tenofovir | |
| GB201602857D0 (en) | Connection of rotatable parts | |
| GB201600964D0 (en) | Determination of vehicle capabilities | |
| IL254666A0 (en) | Crystalline forms of Aldecalcitol | |
| HUP1500506A2 (en) | Salts of palbociclib | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| IL249332A0 (en) | Crystalline forms of sofosbuvir | |
| GB201519795D0 (en) | Construction of surfaces |